FDA NDC Directory · JSON-LD · Markdown

Mirvaso

NDC 0299-5980 · HUMAN PRESCRIPTION DRUG · GEL

Generic namebrimonidine tartrate
Labeler / ManufacturerGalderma Laboratories, L.P.
Marketing categoryNew Drug Application (innovator) · App NDA204708
Dosage form / routeGEL · TOPICAL
Active ingredientsBRIMONIDINE TARTRATE (5 mg/g)
Marketing started20130823
Package count5

External sources

Source: openFDA. Public-domain (CC0).